Literature DB >> 22826627

Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus.

Yi-Fen Zhang1, Jiong Shi, Hui-Ping Yu, An-Ning Feng, Xiang-Shan Fan, Gregory Y Lauwers, Hiroshi Mashimo, Jason S Gold, Gang Chen, Qin Huang.   

Abstract

AIM: To investigate the clinicopathologic features which predict surgical overall survival in patients with proximal gastric carcinoma involving the esophagus (PGCE).
METHODS: Electronic pathology database established in the Department of Pathology of the Nanjing Drum Tower Hospital was searched for consecutive resection cases of proximal gastric carcinoma over the period from May 2004 through July 2009. Each retrieved pathology report was reviewed and the cases with tumors crossing the gastroesophageal junction line were selected as PGCE. Each tumor was re-staged, following the guidelines on esophageal adenocarcinoma, according to the 7th edition of the American Joint Commission on Cancer Staging Manual. All histology slides were studied along with the pathology report for a retrospective analysis of 13 clinicopathologic features, i.e., age, gender, Helicobacter pylori (H. pylori) infection, surgical modality, Siewert type, tumor Bormann's type, size, differentiation, histology type, surgical margin, lymphovascular and perineural invasion, and pathologic stage in relation to survival after surgical resection. Prognostic factors for overall survival were assessed with uni- and multi-variate analyses.
RESULTS: Patients' mean age was 65 years (range: 47-90 years). The male: female ratio was 3.3. The 1-, 3- and 5-year overall survival rates were 87%, 61% and 32%, respectively. By univariate analysis, age, male gender, H. pylori, tumor Bormann's type, size, histology type, surgical modality, positive surgical margin, lymphovascular invasion, and pT stage were not predictive for overall survival; in contrast, perineural invasion (P = 0.003), poor differentiation (P = 0.0003), > 15 total lymph nodes retrieved (P = 0.008), positive lymph nodes (P = 0.001), and distant metastasis (P = 0.005) predicted poor post-operative overall survival. Celiac axis nodal metastasis was associated with significantly worse overall survival (P = 0.007). By multivariate analysis, ≥ 16 positive nodes (P = 0.018), lymph node ratio > 0.2 (P = 0.003), and overall pathologic stage (P = 0.002) were independent predictors for poor overall survival after resection.
CONCLUSION: Patients with PGCE showed worse overall survival in elderly, high nodal burden and advanced pathologic stage. This cancer may be more accurately staged as gastric, than esophageal, cancer.

Entities:  

Keywords:  Cancer; Esophagus; Gastroesophageal junction; Staging; Stomach

Mesh:

Year:  2012        PMID: 22826627      PMCID: PMC3400864          DOI: 10.3748/wjg.v18.i27.3602

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

Review 1.  Pattern of lymphatic spread of Barrett's cancer.

Authors:  Marcus Feith; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

Review 2.  Extended surgery for cancer of the esophagus and gastroesophageal junction.

Authors:  T Lerut; W Coosemans; G Decker; P De Leyn; J Moons; P Nafteux; D Van Raemdonck
Journal:  J Surg Res       Date:  2004-03       Impact factor: 2.192

3.  Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.

Authors:  Farin Kamangar; Sanford M Dawsey; Martin J Blaser; Guillermo I Perez-Perez; Pirjo Pietinen; Craig J Newschaffer; Christian C Abnet; Demetrius Albanes; Jarmo Virtamo; Philip R Taylor
Journal:  J Natl Cancer Inst       Date:  2006-10-18       Impact factor: 13.506

Review 4.  Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.

Authors:  Sjoerd M Lagarde; Fiebo J W ten Kate; Johannes B Reitsma; Olivier R C Busch; J Jan B van Lanschot
Journal:  J Clin Oncol       Date:  2006-09-10       Impact factor: 44.544

5.  Results of surgical treatment of adenocarcinoma of the gastric cardia.

Authors:  Giovanni de Manzoni; Corrado Pedrazzani; Felice Pasini; Alberto Di Leo; Emilia Durante; Gabriele Castaldini; Claudio Cordiano
Journal:  Ann Thorac Surg       Date:  2002-04       Impact factor: 4.330

6.  Outcome of ratio of lymph node metastasis in gastric carcinoma.

Authors:  Etsuro Bando; Yutaka Yonemura; Keizo Taniguchi; Sachio Fushida; Takashi Fujimura; Koichi Miwa
Journal:  Ann Surg Oncol       Date:  2002-10       Impact factor: 5.344

7.  Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.

Authors:  Mohamad A Eloubeidi; Renee Desmond; Miguel R Arguedas; Carolyn E Reed; C Mel Wilcox
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

8.  Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience.

Authors:  Donato Nitti; Alberto Marchet; Matteo Olivieri; Alessandro Ambrosi; Roberto Mencarelli; Claudio Belluco; Mario Lise
Journal:  Ann Surg Oncol       Date:  2003-11       Impact factor: 5.344

9.  Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction.

Authors:  T Lerut; W Coosemans; G Decker; P De Leyn; N Ectors; S Fieuws; J Moons; P Nafteux; D Van Raemdonck
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

10.  Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement.

Authors:  H Akiyama; M Tsurumaru; T Kawamura; Y Ono
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

View more
  14 in total

1.  Differences in HER2 over-expression between proximal and distal gastric cancers in the Chinese population.

Authors:  Xiang-Shan Fan; Jie-Yu Chen; Chang-Feng Li; Yi-Fen Zhang; Fan-Qing Meng; Hong-Yan Wu; An-Ning Feng; Qin Huang
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

2.  Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer.

Authors:  Jennifer M Kolb; Umut Ozbek; Noam Harpaz; Randall F Holcombe; Celina Ang
Journal:  J Gastrointest Oncol       Date:  2017-06

3.  The unique phenotypes of adenocarcinoma of the esophagogastric junction in China.

Authors:  Min Feng; Wenxian Guan
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

4.  Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Jian-Kun Hu
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

5.  Helicobacter pylori infection predicts favorable outcome in patients with gastric cancer.

Authors:  F Wang; G P Sun; Y F Zou; F Zhong; T Ma; X Q Li; D Wu
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

6.  Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.

Authors:  Yuling Zhang; Ditian Liu; Chunfa Chen
Journal:  J Gastrointest Cancer       Date:  2021-09

Review 7.  Carcinoma of the gastroesophageal junction in Chinese patients.

Authors:  Qin Huang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 8.  Resection line involvement after gastric cancer treatment: handle with care.

Authors:  Paolo Morgagni; Giuliano La Barba; Eleonora Colciago; Giovanni Vittimberga; Giorgio Ercolani
Journal:  Updates Surg       Date:  2018-06-23

9.  Incidence of microscopically positive proximal margins in adenocarcinoma of the gastroesophageal junction.

Authors:  Fei Gao; Jia Chen; Tao Wang; Gang Wang; Zhihong Zhang; Lizong Shen
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

10.  Protective role of Helicobacter pylori infection in prognosis of gastric cancer: evidence from 2,454 patients with gastric cancer.

Authors:  Fang Wang; Guoping Sun; Yanfeng Zou; Fei Zhong; Tai Ma; Xiaoqiu Li
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.